Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Zeitlinger

Showing results (61-70 of 352) with videos related to

Pageof 36
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 14, 2024
Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicansAlina Nussbaumer-Pröll, Peter Matzneller, Sabine Eberl, et al.
Wiener Medizinische Wochenschrift (1946)|February 20, 2009
"Iatrogenicity cascade": doing harm by treating harm?Claudia Christina Wagner, Jerome Biollaz, Markus Zeitlinger, et al.
The Journal of Antimicrobial Chemotherapy|May 22, 2026
Efficacy of ceftazidime/avibactam against 10 clinical isolates of Pseudomonas aeruginosa in icodextrin-based peritoneal dialysis solution and patient-derived dialysateStephanie Supparitsch, Andreas Vychytil, Markus Zeitlinger, et al.
Research in Microbiology|January 3, 2012
Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluidRichard Schwameis, Manfred Fille, Mohammad Manafi, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
Penetration of doripenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteersBernhard Burian, Markus Zeitlinger, Oliver Donath, et al.
Frontiers in Pharmacology|February 13, 2023
Orphan drugs' clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursementHans-Georg Eichler, Michael Kossmeier, Markus Zeitlinger, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 25, 2023
Individualized antimicrobial dose optimization: a systematic review and meta-analysis of randomized controlled trialsMaria Sanz-Codina, Haktan Övul Bozkir, Anselm Jorda, et al.
The American Journal of Tropical Medicine and Hygiene|September 4, 2025
Efficacy of Spatial Repellents in Malaria Prevention: A Meta-Analysis of Randomized Controlled TrialsMarlene Prager, Felix Bergmann, Lena Pracher, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysisFriederike Traunmüller, Markus Zeitlinger, Petra Zeleny, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 8, 2019
A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposureSami Ullah, Peter Matzneller, Markus Zeitlinger, et al.
Pageof 36

Showing results (61-70 of 352) with videos related to

Sort By:
Pageof 36
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 14, 2024
Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicansAlina Nussbaumer-Pröll, Peter Matzneller, Sabine Eberl, et al.
Wiener Medizinische Wochenschrift (1946)|February 20, 2009
"Iatrogenicity cascade": doing harm by treating harm?Claudia Christina Wagner, Jerome Biollaz, Markus Zeitlinger, et al.
The Journal of Antimicrobial Chemotherapy|May 22, 2026
Efficacy of ceftazidime/avibactam against 10 clinical isolates of Pseudomonas aeruginosa in icodextrin-based peritoneal dialysis solution and patient-derived dialysateStephanie Supparitsch, Andreas Vychytil, Markus Zeitlinger, et al.
Research in Microbiology|January 3, 2012
Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluidRichard Schwameis, Manfred Fille, Mohammad Manafi, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
Penetration of doripenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteersBernhard Burian, Markus Zeitlinger, Oliver Donath, et al.
Frontiers in Pharmacology|February 13, 2023
Orphan drugs' clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursementHans-Georg Eichler, Michael Kossmeier, Markus Zeitlinger, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 25, 2023
Individualized antimicrobial dose optimization: a systematic review and meta-analysis of randomized controlled trialsMaria Sanz-Codina, Haktan Övul Bozkir, Anselm Jorda, et al.
The American Journal of Tropical Medicine and Hygiene|September 4, 2025
Efficacy of Spatial Repellents in Malaria Prevention: A Meta-Analysis of Randomized Controlled TrialsMarlene Prager, Felix Bergmann, Lena Pracher, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysisFriederike Traunmüller, Markus Zeitlinger, Petra Zeleny, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 8, 2019
A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposureSami Ullah, Peter Matzneller, Markus Zeitlinger, et al.
Pageof 36